Thermo Fisher Scientific Invests $40 Million to Expand Bioprocessing Manufacturing Site

SourceBioPharm International Editors
Date Published02/17/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Thermo Fisher Scientific
Parent companyThermo Fisher Scientific
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):100
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2023
Capital investment ($):40
City reshored to:Millersburg
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredsingle use tech for pharma
What domestic positive factors made reshoring more attractive?Eco-system synergies, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market
Find Reshoring Articles